Biogen (BIIB) Net Income - Minority (2009 - 2023)

Biogen (BIIB) recorded quarterly Net Income - Minority of $4.1 million in Q3 2023, down 35.94% quarter-over-quarter from $6.4 million in Q2 2023, and down 52.87% on a YoY basis from $8.7 million in Q3 2022.

Biogen (BIIB) Net Income - Minority (2009 - 2023) Analysis & Trends

Biogen's Net Income - Minority history runs 15 years deep, the most recent figure standing at $4.1 million for Q3 2023.

  • In Q3 2023, Net Income - Minority fell 52.87% year-over-year to $4.1 million; the TTM figure through Sep 2023 stood at $4.1 million (down 52.87% YoY), while the FY2022 annual figure was $9.5 million, up 114.96% from the prior year.
  • Net Income - Minority was $4.1 million for Q3 2023 at Biogen, down from $6.4 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of $21.6 million in Q1 2022 to a low of -$462.9 million in Q2 2021.
  • Historically, Net Income - Minority has averaged -$42.8 million across 5 years, with a median of $8.7 million in 2022.
  • The sharpest annual moves came in 2020 and 2021: Net Income - Minority jumped 375.61% in 2020, then slumped 3327.14% in 2021.
  • A 5-year view of Net Income - Minority shows it stood at $4.1 million in 2019, then soared by 246.34% to $14.2 million in 2020, then tumbled by 547.18% to -$63.5 million in 2021, then soared by 114.96% to $9.5 million in 2022, then sank by 56.84% to $4.1 million in 2023.
  • The last three Net Income - Minority figures came in at $4.1 million (Q3 2023), $6.4 million (Q2 2023), and $9.6 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Biogen 28.75 Bn 24.47 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2023 4.10 Mn
Jun 30, 2023 6.40 Mn
Mar 31, 2023 9.60 Mn
Dec 31, 2022 9.50 Mn
Sep 30, 2022 8.70 Mn
Jun 30, 2022 9.10 Mn
Mar 31, 2022 21.60 Mn
Dec 31, 2021 -63.50 Mn
Sep 30, 2021 -451.80 Mn
Jun 30, 2021 -462.90 Mn
Mar 31, 2021 19.00 Mn
Dec 31, 2020 14.20 Mn
Sep 30, 2020 14.00 Mn
Jun 30, 2020 19.50 Mn
Mar 31, 2020 10.00 Mn
Dec 31, 2019 4.10 Mn
Sep 30, 2019 4.10 Mn
Jun 30, 2019 4.10 Mn
Mar 31, 2019 7.90 Mn
Dec 31, 2018 8.00 Mn